Canada markets open in 3 hours 15 minutes

AbbVie Inc. (ABBV)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
178.09+1.34 (+0.76%)
At close: 04:00PM EST
178.14 +0.05 (+0.03%)
Pre-Market: 05:59AM EST
Full screen
Trade prices are not sourced from all markets
Previous Close176.75
Bid178.13 x 800
Ask179.10 x 800
Day's Range177.01 - 178.90
52 Week Range130.96 - 178.92
Avg. Volume5,459,190
Market Cap314.591B
Beta (5Y Monthly)0.54
PE Ratio (TTM)65.47
Earnings DateN/A
Forward Dividend & Yield6.20 (3.48%)
Ex-Dividend DateApr 12, 2024
1y Target EstN/A
  • PR Newswire

    AbbVie and Tentarix Announce Collaboration to Develop Conditionally-Active, Multi-Specific Biologics for Oncology and Immunology

    AbbVie Inc. (NYSE: ABBV) and Tentarix Biotherapeutics today announced a multi-year collaboration focused on the discovery and development of conditionally-active, multi-specific biologic candidates in oncology and immunology. The collaboration will integrate AbbVie's expertise in oncology and immunology with Tentarix's proprietary Tentacles™ platform.

  • PR Newswire

    BOTOX® Cosmetic (onabotulinumtoxinA) Announces Its 2024 Grant Program Supporting Women Entrepreneurs

    Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced that applications are open for the 2024 BOTOX® Cosmetic grant program supporting women entrepreneurs. BOTOX® Cosmetic partnered with IFundWomen to launch the program in 2023, and in the second year, will award a new group of 20 women entrepreneurs each with $25,000 grants to fund and grow their businesses. Additionally, BOTOX® Cosmetic continues to support these businesses through mentorship, coaching, crowdfunding, and commun

  • PR Newswire

    AbbVie Announces Appointment of Robert A. Michael as Chief Executive Officer

    AbbVie (NYSE: ABBV) today announced that its board of directors has unanimously selected Robert A. Michael, AbbVie's current president and chief operating officer, to succeed Richard A. Gonzalez as the company's chief executive officer (CEO). Mr. Gonzalez, who has served as CEO since the company's formation in 2013, will retire from the role of CEO and become executive chairman of the board of directors, effective July 1, 2024. Additionally, the board has appointed Mr. Michael as a member of the